MNOV logo

MediciNova (MNOV) EBITDA

Annual EBITDA

-$9.88 M
+$4.73 M+32.38%

December 31, 2023


Summary


Performance

MNOV EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMNOVprofitabilitymetrics:

Quarterly EBITDA

-$3.30 M
-$262.80 K-8.64%

September 30, 2024


Summary


Performance

MNOV Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMNOVprofitabilitymetrics:

TTM EBITDA

-$11.96 M
-$2.16 M-22.07%

September 30, 2024


Summary


Performance

MNOV TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMNOVprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

MNOV EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.4%-5.5%-19.0%
3 y3 years+30.2%-0.3%+10.6%
5 y5 years+36.5%-0.3%+10.6%

MNOV EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+32.4%-189.5%+19.1%-22.1%+18.1%
5 y5-yearat high+32.4%-1593.4%+26.7%-22.1%+18.1%
alltimeall time-390.3%+81.3%-196.5%+84.2%-268.2%+80.8%

MediciNova EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.30 M(+8.6%)
-$11.96 M(+22.1%)
Jun 2024
-
-$3.04 M(-2.9%)
-$9.80 M(-2.5%)
Mar 2024
-
-$3.13 M(+26.0%)
-$10.05 M(+1.7%)
Dec 2023
-$9.88 M(-32.4%)
-$2.48 M(+117.7%)
-$9.88 M(-7.0%)
Sep 2023
-
-$1.14 M(-65.4%)
-$10.62 M(-20.6%)
Jun 2023
-
-$3.29 M(+11.4%)
-$13.37 M(-5.6%)
Mar 2023
-
-$2.96 M(-8.3%)
-$14.16 M(-3.1%)
Dec 2022
-$14.61 M(+43.4%)
-$3.23 M(-17.1%)
-$14.61 M(+8.4%)
Sep 2022
-
-$3.89 M(-4.7%)
-$13.48 M(+2.3%)
Jun 2022
-
-$4.09 M(+20.0%)
-$13.18 M(-1.6%)
Mar 2022
-
-$3.41 M(+62.4%)
-$13.40 M(+31.5%)
Dec 2021
-$10.19 M(-28.0%)
-$2.10 M(-41.7%)
-$10.19 M(-8.2%)
Sep 2021
-
-$3.59 M(-16.5%)
-$11.10 M(-1.2%)
Jun 2021
-
-$4.30 M(+2105.7%)
-$11.23 M(-1.8%)
Mar 2021
-
-$195.10 K(-93.5%)
-$11.43 M(-19.2%)
Dec 2020
-$14.16 M(+1.1%)
-$3.01 M(-19.3%)
-$14.16 M(+5.9%)
Sep 2020
-
-$3.72 M(-17.3%)
-$13.37 M(+8.8%)
Jun 2020
-
-$4.51 M(+54.3%)
-$12.28 M(+2.8%)
Mar 2020
-
-$2.92 M(+31.6%)
-$11.95 M(-14.7%)
Dec 2019
-$14.01 M(-10.0%)
-$2.22 M(-16.0%)
-$14.01 M(+14.1%)
Sep 2019
-
-$2.64 M(-36.8%)
-$12.27 M(-26.3%)
Jun 2019
-
-$4.18 M(-16.0%)
-$16.66 M(+4.9%)
Mar 2019
-
-$4.97 M(+923.1%)
-$15.87 M(+2.0%)
Dec 2018
-$15.56 M(+19.7%)
-$486.10 K(-93.1%)
-$15.56 M(-15.8%)
Sep 2018
-
-$7.02 M(+106.9%)
-$18.48 M(+21.2%)
Jun 2018
-
-$3.39 M(-27.2%)
-$15.24 M(+4.1%)
Mar 2018
-
-$4.66 M(+37.0%)
-$14.64 M(+12.6%)
Dec 2017
-$13.00 M(+19.6%)
-$3.40 M(-10.1%)
-$13.00 M(+17.8%)
Sep 2017
-
-$3.78 M(+35.3%)
-$11.04 M(+9.3%)
Jun 2017
-
-$2.80 M(-7.2%)
-$10.09 M(-3.8%)
Mar 2017
-
-$3.02 M(+109.8%)
-$10.50 M(-3.4%)
Dec 2016
-$10.87 M(+23.3%)
-$1.44 M(-49.4%)
-$10.87 M(-10.8%)
Sep 2016
-
-$2.84 M(-11.2%)
-$12.18 M(+11.5%)
Jun 2016
-
-$3.20 M(-5.5%)
-$10.92 M(+9.3%)
Mar 2016
-
-$3.39 M(+23.3%)
-$9.99 M(+13.4%)
Dec 2015
-$8.81 M(-3.8%)
-$2.75 M(+72.9%)
-$8.81 M(+4.7%)
Sep 2015
-
-$1.59 M(-30.0%)
-$8.41 M(-8.1%)
Jun 2015
-
-$2.27 M(+2.8%)
-$9.16 M(+1.6%)
Mar 2015
-
-$2.21 M(-6.1%)
-$9.01 M(-1.5%)
Dec 2014
-$9.16 M(+133.4%)
-$2.35 M(+0.6%)
-$9.15 M(+171.2%)
Sep 2014
-
-$2.34 M(+10.1%)
-$3.37 M(+3.8%)
Jun 2014
-
-$2.12 M(-9.4%)
-$3.25 M(-16.2%)
Mar 2014
-
-$2.34 M(-168.3%)
-$3.88 M(-1.2%)
DateAnnualQuarterlyTTM
Dec 2013
-$3.92 M(-63.9%)
$3.42 M(-254.9%)
-$3.92 M(-59.7%)
Sep 2013
-
-$2.21 M(-19.6%)
-$9.74 M(-1.4%)
Jun 2013
-
-$2.75 M(+15.2%)
-$9.88 M(+5.1%)
Mar 2013
-
-$2.39 M(-0.1%)
-$9.40 M(-13.5%)
Dec 2012
-$10.88 M(-32.4%)
-$2.39 M(+1.5%)
-$10.88 M(-9.1%)
Sep 2012
-
-$2.35 M(+3.5%)
-$11.97 M(-11.4%)
Jun 2012
-
-$2.27 M(-41.1%)
-$13.51 M(-9.7%)
Mar 2012
-
-$3.86 M(+10.8%)
-$14.97 M(-7.0%)
Dec 2011
-$16.09 M(-12.1%)
-$3.48 M(-10.6%)
-$16.10 M(-4.9%)
Sep 2011
-
-$3.90 M(+4.6%)
-$16.92 M(-6.2%)
Jun 2011
-
-$3.73 M(-25.3%)
-$18.04 M(-1.0%)
Mar 2011
-
-$4.99 M(+15.9%)
-$18.21 M(-0.5%)
Dec 2010
-$18.30 M(-8.1%)
-$4.31 M(-14.1%)
-$18.30 M(-7.5%)
Sep 2010
-
-$5.01 M(+28.5%)
-$19.78 M(+1.7%)
Jun 2010
-
-$3.90 M(-23.2%)
-$19.46 M(-3.1%)
Mar 2010
-
-$5.08 M(-12.3%)
-$20.09 M(-0.6%)
Dec 2009
-$19.90 M(-10.7%)
-$5.79 M(+23.4%)
-$20.21 M(+15.9%)
Sep 2009
-
-$4.69 M(+3.5%)
-$17.44 M(-5.1%)
Jun 2009
-
-$4.53 M(-12.9%)
-$18.38 M(+0.7%)
Mar 2009
-
-$5.20 M(+72.4%)
-$18.25 M(-15.9%)
Dec 2008
-$22.30 M(-57.9%)
-$3.02 M(-46.4%)
-$21.71 M(-3.3%)
Sep 2008
-
-$5.63 M(+28.0%)
-$22.45 M(-19.9%)
Jun 2008
-
-$4.40 M(-49.2%)
-$28.02 M(-37.0%)
Mar 2008
-
-$8.66 M(+130.7%)
-$44.51 M(-16.4%)
Dec 2007
-$52.98 M(+27.1%)
-$3.75 M(-66.5%)
-$53.26 M(-14.7%)
Sep 2007
-
-$11.21 M(-46.3%)
-$62.45 M(+1.9%)
Jun 2007
-
-$20.89 M(+19.9%)
-$61.31 M(+24.8%)
Mar 2007
-
-$17.41 M(+34.5%)
-$49.11 M(+18.2%)
Dec 2006
-$41.68 M(+38.5%)
-$12.95 M(+28.7%)
-$41.56 M(+11.8%)
Sep 2006
-
-$10.06 M(+15.8%)
-$37.15 M(+6.8%)
Jun 2006
-
-$8.69 M(-11.8%)
-$34.80 M(+1.0%)
Mar 2006
-
-$9.86 M(+15.3%)
-$34.45 M(+14.6%)
Dec 2005
-$30.09 M(-38.0%)
-$8.54 M(+10.9%)
-$30.06 M(+17.2%)
Sep 2005
-
-$7.71 M(-7.6%)
-$25.64 M(-28.1%)
Jun 2005
-
-$8.34 M(+52.3%)
-$35.66 M(-24.7%)
Mar 2005
-
-$5.48 M(+32.8%)
-$47.36 M(-2.5%)
Dec 2004
-$48.57 M(+679.4%)
-$4.12 M(-76.7%)
-$48.57 M(+9.3%)
Sep 2004
-
-$17.72 M(-11.6%)
-$44.44 M(+66.3%)
Jun 2004
-
-$20.04 M(+199.8%)
-$26.73 M(+299.8%)
Mar 2004
-
-$6.68 M
-$6.68 M
Dec 2003
-$6.23 M(-11.1%)
-
-
Dec 2002
-$7.01 M(+248.0%)
-
-
Dec 2001
-$2.02 M
-
-

FAQ

  • What is MediciNova annual EBITDA?
  • What is the all time high annual EBITDA for MediciNova?
  • What is MediciNova annual EBITDA year-on-year change?
  • What is MediciNova quarterly EBITDA?
  • What is the all time high quarterly EBITDA for MediciNova?
  • What is MediciNova quarterly EBITDA year-on-year change?
  • What is MediciNova TTM EBITDA?
  • What is the all time high TTM EBITDA for MediciNova?
  • What is MediciNova TTM EBITDA year-on-year change?

What is MediciNova annual EBITDA?

The current annual EBITDA of MNOV is -$9.88 M

What is the all time high annual EBITDA for MediciNova?

MediciNova all-time high annual EBITDA is -$2.02 M

What is MediciNova annual EBITDA year-on-year change?

Over the past year, MNOV annual EBITDA has changed by +$4.73 M (+32.38%)

What is MediciNova quarterly EBITDA?

The current quarterly EBITDA of MNOV is -$3.30 M

What is the all time high quarterly EBITDA for MediciNova?

MediciNova all-time high quarterly EBITDA is $3.42 M

What is MediciNova quarterly EBITDA year-on-year change?

Over the past year, MNOV quarterly EBITDA has changed by -$173.30 K (-5.54%)

What is MediciNova TTM EBITDA?

The current TTM EBITDA of MNOV is -$11.96 M

What is the all time high TTM EBITDA for MediciNova?

MediciNova all-time high TTM EBITDA is -$3.25 M

What is MediciNova TTM EBITDA year-on-year change?

Over the past year, MNOV TTM EBITDA has changed by -$1.91 M (-18.99%)